 | • レポートコード：QYR2104Z0981 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、脳腫瘍治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法）、用途別市場規模（早期、中期、後期）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・脳腫瘍治療の市場動向 ・企業の競争状況、市場シェア ・脳腫瘍治療の種類別市場規模（化学療法、標的療法） ・脳腫瘍治療の用途別市場規模（早期、中期、後期） ・脳腫瘍治療の北米市場規模2016-2027（アメリカ、カナダ） ・脳腫瘍治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・脳腫瘍治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・脳腫瘍治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・脳腫瘍治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Genetech (U.S.)、Bristol Mayers Squibb (U.S.)、Hoffman-La Roche (Switzerland)、Astra Zeneca (India)、Pfizer (U.S.)、Novartis (Switzerland)、Antisenese Pharma (Mongolia)、Merck (U.S.)、Mcleod’s Pharmaceuticals (India)、Mankind Pharma (India)、Dr. Reddy’s Laboratories (India)） ・結論 |
Treatment for brain tumors depends on a number of factors including the type, location and size of the tumor as well as the patient’s age and general health.
Various treatments for curing brain tumor are surgery, radiation therapy, and chemotherapy, immunotherapy and so on which reduce the symptoms and slow down the tumor’s growth.
Market Analysis and Insights: Global Brain Tumor Treatment Market
The global Brain Tumor Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Brain Tumor Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Brain Tumor Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Brain Tumor Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Brain Tumor Treatment market.
Global Brain Tumor Treatment Scope and Market Size
Brain Tumor Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Brain Tumor Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chemotherapy
Targeted Therapy
Segment by Application
Early
Mid-term
Later period
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Genetech (U.S.)
Bristol Mayers Squibb (U.S.)
Hoffman-La Roche (Switzerland)
Astra Zeneca (India)
Pfizer (U.S.)
Novartis (Switzerland)
Antisenese Pharma (Mongolia)
Merck (U.S.)
Mcleod’s Pharmaceuticals (India)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brain Tumor Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.3 Market by Application
1.3.1 Global Brain Tumor Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Early
1.3.3 Mid-term
1.3.4 Later period
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Brain Tumor Treatment Market Perspective (2016-2027)
2.2 Brain Tumor Treatment Growth Trends by Regions
2.2.1 Brain Tumor Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Brain Tumor Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Brain Tumor Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Brain Tumor Treatment Industry Dynamic
2.3.1 Brain Tumor Treatment Market Trends
2.3.2 Brain Tumor Treatment Market Drivers
2.3.3 Brain Tumor Treatment Market Challenges
2.3.4 Brain Tumor Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Brain Tumor Treatment Players by Revenue
3.1.1 Global Top Brain Tumor Treatment Players by Revenue (2016-2021)
3.1.2 Global Brain Tumor Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Brain Tumor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Brain Tumor Treatment Revenue
3.4 Global Brain Tumor Treatment Market Concentration Ratio
3.4.1 Global Brain Tumor Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain Tumor Treatment Revenue in 2020
3.5 Brain Tumor Treatment Key Players Head office and Area Served
3.6 Key Players Brain Tumor Treatment Product Solution and Service
3.7 Date of Enter into Brain Tumor Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Brain Tumor Treatment Breakdown Data by Type
4.1 Global Brain Tumor Treatment Historic Market Size by Type (2016-2021)
4.2 Global Brain Tumor Treatment Forecasted Market Size by Type (2022-2027)
5 Brain Tumor Treatment Breakdown Data by Application
5.1 Global Brain Tumor Treatment Historic Market Size by Application (2016-2021)
5.2 Global Brain Tumor Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Brain Tumor Treatment Market Size (2016-2027)
6.2 North America Brain Tumor Treatment Market Size by Type
6.2.1 North America Brain Tumor Treatment Market Size by Type (2016-2021)
6.2.2 North America Brain Tumor Treatment Market Size by Type (2022-2027)
6.2.3 North America Brain Tumor Treatment Market Size by Type (2016-2027)
6.3 North America Brain Tumor Treatment Market Size by Application
6.3.1 North America Brain Tumor Treatment Market Size by Application (2016-2021)
6.3.2 North America Brain Tumor Treatment Market Size by Application (2022-2027)
6.3.3 North America Brain Tumor Treatment Market Size by Application (2016-2027)
6.4 North America Brain Tumor Treatment Market Size by Country
6.4.1 North America Brain Tumor Treatment Market Size by Country (2016-2021)
6.4.2 North America Brain Tumor Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Brain Tumor Treatment Market Size (2016-2027)
7.2 Europe Brain Tumor Treatment Market Size by Type
7.2.1 Europe Brain Tumor Treatment Market Size by Type (2016-2021)
7.2.2 Europe Brain Tumor Treatment Market Size by Type (2022-2027)
7.2.3 Europe Brain Tumor Treatment Market Size by Type (2016-2027)
7.3 Europe Brain Tumor Treatment Market Size by Application
7.3.1 Europe Brain Tumor Treatment Market Size by Application (2016-2021)
7.3.2 Europe Brain Tumor Treatment Market Size by Application (2022-2027)
7.3.3 Europe Brain Tumor Treatment Market Size by Application (2016-2027)
7.4 Europe Brain Tumor Treatment Market Size by Country
7.4.1 Europe Brain Tumor Treatment Market Size by Country (2016-2021)
7.4.2 Europe Brain Tumor Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Brain Tumor Treatment Market Size (2016-2027)
8.2 Asia-Pacific Brain Tumor Treatment Market Size by Type
8.2.1 Asia-Pacific Brain Tumor Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Brain Tumor Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Brain Tumor Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Brain Tumor Treatment Market Size by Application
8.3.1 Asia-Pacific Brain Tumor Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Brain Tumor Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Brain Tumor Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Brain Tumor Treatment Market Size by Region
8.4.1 Asia-Pacific Brain Tumor Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Brain Tumor Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Brain Tumor Treatment Market Size (2016-2027)
9.2 Latin America Brain Tumor Treatment Market Size by Type
9.2.1 Latin America Brain Tumor Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Brain Tumor Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Brain Tumor Treatment Market Size by Type (2016-2027)
9.3 Latin America Brain Tumor Treatment Market Size by Application
9.3.1 Latin America Brain Tumor Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Brain Tumor Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Brain Tumor Treatment Market Size by Application (2016-2027)
9.4 Latin America Brain Tumor Treatment Market Size by Country
9.4.1 Latin America Brain Tumor Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Brain Tumor Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Brain Tumor Treatment Market Size (2016-2027)
10.2 Middle East & Africa Brain Tumor Treatment Market Size by Type
10.2.1 Middle East & Africa Brain Tumor Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Brain Tumor Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Brain Tumor Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Brain Tumor Treatment Market Size by Application
10.3.1 Middle East & Africa Brain Tumor Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Brain Tumor Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Brain Tumor Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Brain Tumor Treatment Market Size by Country
10.4.1 Middle East & Africa Brain Tumor Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Brain Tumor Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Genetech (U.S.)
11.1.1 Genetech (U.S.) Company Details
11.1.2 Genetech (U.S.) Business Overview
11.1.3 Genetech (U.S.) Brain Tumor Treatment Introduction
11.1.4 Genetech (U.S.) Revenue in Brain Tumor Treatment Business (2016-2021)
11.1.5 Genetech (U.S.) Recent Development
11.2 Bristol Mayers Squibb (U.S.)
11.2.1 Bristol Mayers Squibb (U.S.) Company Details
11.2.2 Bristol Mayers Squibb (U.S.) Business Overview
11.2.3 Bristol Mayers Squibb (U.S.) Brain Tumor Treatment Introduction
11.2.4 Bristol Mayers Squibb (U.S.) Revenue in Brain Tumor Treatment Business (2016-2021)
11.2.5 Bristol Mayers Squibb (U.S.) Recent Development
11.3 Hoffman-La Roche (Switzerland)
11.3.1 Hoffman-La Roche (Switzerland) Company Details
11.3.2 Hoffman-La Roche (Switzerland) Business Overview
11.3.3 Hoffman-La Roche (Switzerland) Brain Tumor Treatment Introduction
11.3.4 Hoffman-La Roche (Switzerland) Revenue in Brain Tumor Treatment Business (2016-2021)
11.3.5 Hoffman-La Roche (Switzerland) Recent Development
11.4 Astra Zeneca (India)
11.4.1 Astra Zeneca (India) Company Details
11.4.2 Astra Zeneca (India) Business Overview
11.4.3 Astra Zeneca (India) Brain Tumor Treatment Introduction
11.4.4 Astra Zeneca (India) Revenue in Brain Tumor Treatment Business (2016-2021)
11.4.5 Astra Zeneca (India) Recent Development
11.5 Pfizer (U.S.)
11.5.1 Pfizer (U.S.) Company Details
11.5.2 Pfizer (U.S.) Business Overview
11.5.3 Pfizer (U.S.) Brain Tumor Treatment Introduction
11.5.4 Pfizer (U.S.) Revenue in Brain Tumor Treatment Business (2016-2021)
11.5.5 Pfizer (U.S.) Recent Development
11.6 Novartis (Switzerland)
11.6.1 Novartis (Switzerland) Company Details
11.6.2 Novartis (Switzerland) Business Overview
11.6.3 Novartis (Switzerland) Brain Tumor Treatment Introduction
11.6.4 Novartis (Switzerland) Revenue in Brain Tumor Treatment Business (2016-2021)
11.6.5 Novartis (Switzerland) Recent Development
11.7 Antisenese Pharma (Mongolia)
11.7.1 Antisenese Pharma (Mongolia) Company Details
11.7.2 Antisenese Pharma (Mongolia) Business Overview
11.7.3 Antisenese Pharma (Mongolia) Brain Tumor Treatment Introduction
11.7.4 Antisenese Pharma (Mongolia) Revenue in Brain Tumor Treatment Business (2016-2021)
11.7.5 Antisenese Pharma (Mongolia) Recent Development
11.8 Merck (U.S.)
11.8.1 Merck (U.S.) Company Details
11.8.2 Merck (U.S.) Business Overview
11.8.3 Merck (U.S.) Brain Tumor Treatment Introduction
11.8.4 Merck (U.S.) Revenue in Brain Tumor Treatment Business (2016-2021)
11.8.5 Merck (U.S.) Recent Development
11.9 Mcleod’s Pharmaceuticals (India)
11.9.1 Mcleod’s Pharmaceuticals (India) Company Details
11.9.2 Mcleod’s Pharmaceuticals (India) Business Overview
11.9.3 Mcleod’s Pharmaceuticals (India) Brain Tumor Treatment Introduction
11.9.4 Mcleod’s Pharmaceuticals (India) Revenue in Brain Tumor Treatment Business (2016-2021)
11.9.5 Mcleod’s Pharmaceuticals (India) Recent Development
11.10 Mankind Pharma (India)
11.10.1 Mankind Pharma (India) Company Details
11.10.2 Mankind Pharma (India) Business Overview
11.10.3 Mankind Pharma (India) Brain Tumor Treatment Introduction
11.10.4 Mankind Pharma (India) Revenue in Brain Tumor Treatment Business (2016-2021)
11.10.5 Mankind Pharma (India) Recent Development
11.11 Dr. Reddy’s Laboratories (India)
11.11.1 Dr. Reddy’s Laboratories (India) Company Details
11.11.2 Dr. Reddy’s Laboratories (India) Business Overview
11.11.3 Dr. Reddy’s Laboratories (India) Brain Tumor Treatment Introduction
11.11.4 Dr. Reddy’s Laboratories (India) Revenue in Brain Tumor Treatment Business (2016-2021)
11.11.5 Dr. Reddy’s Laboratories (India) Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Brain Tumor Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Targeted Therapy
Table 4. Global Brain Tumor Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Brain Tumor Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Brain Tumor Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Brain Tumor Treatment Market Share by Regions (2016-2021)
Table 8. Global Brain Tumor Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Brain Tumor Treatment Market Share by Regions (2022-2027)
Table 10. Brain Tumor Treatment Market Trends
Table 11. Brain Tumor Treatment Market Drivers
Table 12. Brain Tumor Treatment Market Challenges
Table 13. Brain Tumor Treatment Market Restraints
Table 14. Global Brain Tumor Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Brain Tumor Treatment Market Share by Players (2016-2021)
Table 16. Global Top Brain Tumor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brain Tumor Treatment as of 2020)
Table 17. Ranking of Global Top Brain Tumor Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Brain Tumor Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Brain Tumor Treatment Product Solution and Service
Table 21. Date of Enter into Brain Tumor Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Brain Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Brain Tumor Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Brain Tumor Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Brain Tumor Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Brain Tumor Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Brain Tumor Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Brain Tumor Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Brain Tumor Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Brain Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Brain Tumor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Brain Tumor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Brain Tumor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Brain Tumor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Brain Tumor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Brain Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Brain Tumor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Brain Tumor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Brain Tumor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Brain Tumor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Brain Tumor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Brain Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Brain Tumor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Brain Tumor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Brain Tumor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Brain Tumor Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Brain Tumor Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Brain Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Brain Tumor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Brain Tumor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Brain Tumor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Brain Tumor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Brain Tumor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Brain Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Brain Tumor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Brain Tumor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Brain Tumor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Brain Tumor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Brain Tumor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Genetech (U.S.) Company Details
Table 62. Genetech (U.S.) Business Overview
Table 63. Genetech (U.S.) Brain Tumor Treatment Product
Table 64. Genetech (U.S.) Revenue in Brain Tumor Treatment Business (2016-2021) & (US$ Million)
Table 65. Genetech (U.S.) Recent Development
Table 66. Bristol Mayers Squibb (U.S.) Company Details
Table 67. Bristol Mayers Squibb (U.S.) Business Overview
Table 68. Bristol Mayers Squibb (U.S.) Brain Tumor Treatment Product
Table 69. Bristol Mayers Squibb (U.S.) Revenue in Brain Tumor Treatment Business (2016-2021) & (US$ Million)
Table 70. Bristol Mayers Squibb (U.S.) Recent Development
Table 71. Hoffman-La Roche (Switzerland) Company Details
Table 72. Hoffman-La Roche (Switzerland) Business Overview
Table 73. Hoffman-La Roche (Switzerland) Brain Tumor Treatment Product
Table 74. Hoffman-La Roche (Switzerland) Revenue in Brain Tumor Treatment Business (2016-2021) & (US$ Million)
Table 75. Hoffman-La Roche (Switzerland) Recent Development
Table 76. Astra Zeneca (India) Company Details
Table 77. Astra Zeneca (India) Business Overview
Table 78. Astra Zeneca (India) Brain Tumor Treatment Product
Table 79. Astra Zeneca (India) Revenue in Brain Tumor Treatment Business (2016-2021) & (US$ Million)
Table 80. Astra Zeneca (India) Recent Development
Table 81. Pfizer (U.S.) Company Details
Table 82. Pfizer (U.S.) Business Overview
Table 83. Pfizer (U.S.) Brain Tumor Treatment Product
Table 84. Pfizer (U.S.) Revenue in Brain Tumor Treatment Business (2016-2021) & (US$ Million)
Table 85. Pfizer (U.S.) Recent Development
Table 86. Novartis (Switzerland) Company Details
Table 87. Novartis (Switzerland) Business Overview
Table 88. Novartis (Switzerland) Brain Tumor Treatment Product
Table 89. Novartis (Switzerland) Revenue in Brain Tumor Treatment Business (2016-2021) & (US$ Million)
Table 90. Novartis (Switzerland) Recent Development
Table 91. Antisenese Pharma (Mongolia) Company Details
Table 92. Antisenese Pharma (Mongolia) Business Overview
Table 93. Antisenese Pharma (Mongolia) Brain Tumor Treatment Product
Table 94. Antisenese Pharma (Mongolia) Revenue in Brain Tumor Treatment Business (2016-2021) & (US$ Million)
Table 95. Antisenese Pharma (Mongolia) Recent Development
Table 96. Merck (U.S.) Company Details
Table 97. Merck (U.S.) Business Overview
Table 98. Merck (U.S.) Revenue in Brain Tumor Treatment Business (2016-2021) & (US$ Million)
Table 99. Merck (U.S.) Recent Development
Table 100. Mcleod’s Pharmaceuticals (India) Company Details
Table 101. Mcleod’s Pharmaceuticals (India) Business Overview
Table 102. Mcleod’s Pharmaceuticals (India) Brain Tumor Treatment Product
Table 103. Mcleod’s Pharmaceuticals (India) Revenue in Brain Tumor Treatment Business (2016-2021) & (US$ Million)
Table 104. Mcleod’s Pharmaceuticals (India) Recent Development
Table 105. Mankind Pharma (India) Company Details
Table 106. Mankind Pharma (India) Business Overview
Table 107. Mankind Pharma (India) Brain Tumor Treatment Product
Table 108. Mankind Pharma (India) Revenue in Brain Tumor Treatment Business (2016-2021) & (US$ Million)
Table 109. Mankind Pharma (India) Recent Development
Table 110. Dr. Reddy’s Laboratories (India) Company Details
Table 111. Dr. Reddy’s Laboratories (India) Business Overview
Table 112. Dr. Reddy’s Laboratories (India) Brain Tumor Treatment Product
Table 113. Dr. Reddy’s Laboratories (India) Revenue in Brain Tumor Treatment Business (2016-2021) & (US$ Million)
Table 114. Dr. Reddy’s Laboratories (India) Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Brain Tumor Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Targeted Therapy Features
Figure 4. Global Brain Tumor Treatment Market Share by Application: 2020 VS 2027
Figure 5. Early Case Studies
Figure 6. Mid-term Case Studies
Figure 7. Later period Case Studies
Figure 8. Brain Tumor Treatment Report Years Considered
Figure 9. Global Brain Tumor Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Brain Tumor Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Brain Tumor Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Brain Tumor Treatment Market Share by Regions (2022-2027)
Figure 13. Global Brain Tumor Treatment Market Share by Players in 2020
Figure 14. Global Top Brain Tumor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brain Tumor Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Brain Tumor Treatment Revenue in 2020
Figure 16. Global Brain Tumor Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Brain Tumor Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Brain Tumor Treatment Market Share by Type (2016-2027)
Figure 20. North America Brain Tumor Treatment Market Share by Application (2016-2027)
Figure 21. North America Brain Tumor Treatment Market Share by Country (2016-2027)
Figure 22. United States Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Brain Tumor Treatment Market Share by Type (2016-2027)
Figure 26. Europe Brain Tumor Treatment Market Share by Application (2016-2027)
Figure 27. Europe Brain Tumor Treatment Market Share by Country (2016-2027)
Figure 28. Germany Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Brain Tumor Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Brain Tumor Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Brain Tumor Treatment Market Share by Region (2016-2027)
Figure 38. China Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Brain Tumor Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Brain Tumor Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Brain Tumor Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Brain Tumor Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Brain Tumor Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Brain Tumor Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Brain Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Genetech (U.S.) Revenue Growth Rate in Brain Tumor Treatment Business (2016-2021)
Figure 58. Bristol Mayers Squibb (U.S.) Revenue Growth Rate in Brain Tumor Treatment Business (2016-2021)
Figure 59. Hoffman-La Roche (Switzerland) Revenue Growth Rate in Brain Tumor Treatment Business (2016-2021)
Figure 60. Astra Zeneca (India) Revenue Growth Rate in Brain Tumor Treatment Business (2016-2021)
Figure 61. Pfizer (U.S.) Revenue Growth Rate in Brain Tumor Treatment Business (2016-2021)
Figure 62. Novartis (Switzerland) Revenue Growth Rate in Brain Tumor Treatment Business (2016-2021)
Figure 63. Antisenese Pharma (Mongolia) Revenue Growth Rate in Brain Tumor Treatment Business (2016-2021)
Figure 64. Merck (U.S.) Revenue Growth Rate in Brain Tumor Treatment Business (2016-2021)
Figure 65. Mcleod’s Pharmaceuticals (India) Revenue Growth Rate in Brain Tumor Treatment Business (2016-2021)
Figure 66. Mankind Pharma (India) Revenue Growth Rate in Brain Tumor Treatment Business (2016-2021)
Figure 67. Dr. Reddy’s Laboratories (India) Revenue Growth Rate in Brain Tumor Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の脳腫瘍治療市場規模・現状・予測（2021年-2027年） A brain tumor occurs when abnormal cells form within the brain. North America dominates the brain tumor therapeutics market due to increasing technological advancements and the rising incidences of brain cancer in the country. Asia-Pacific is also expected to propel the brain tumor therapeutics mark…- 世界の小児脳腫瘍市場規模・現状・予測（2021年-2027年） Pediatric brain tumors are masses or growths of abnormal cells that occur in a child's brain or the tissue and structures that are near it. Many different types of pediatric brain tumors exist — some are noncancerous (benign) and some are cancerous (malignant). Treatment and chance of recovery (prog…
- 世界の脳腫瘍診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Brain Tumor Diagnosis and Therapeutics Market The global Brain Tumor Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis a…
- 世界の脳腫瘍診断・治療市場規模・現状・予測（2021年-2027年） With the increasing prevalence of brain cancer, rising aging population, and growing incidences of cancer via chemical exposure, the demand of Diagnosis and treatment of brain tumors is increasing. Market Analysis and Insights: Global Brain Tumor Diagnosis and Treatments Market The global Brain Tumo…
- 世界の交流電場腫瘍治療市場規模・現状・予測（2021年-2027年） Alternating electric field tumor therapy is an anticancer treatment which disrupts the tumor cells mitosis. Alternating electric field therapy is a low intensity technique which disrupts the division of cells through physical interaction of molecules during mitosis in tumor cancer. The alternating e…